Personal Retriever Logo


Winner of UCSD Direct General Technology Award

Nancy van Dillen
(858) 964-1319

Brian Brokowski
(619) 237-7716

SAN DIEGO (December 2, 2004) - CONNECT, UC San Diego's program in technology and entrepreneurship, today announced the winners for the 17th annual CONNECT Most Innovative New Product (MIP) Awards, reinforcing the region's reputation for supporting emerging technologies and encouraging creative product development.

The winners, announced at a luncheon at the Marriott Hotel & Marina, were chosen from a field of 19 finalists by a distinguished panel of judges representing leaders from San Diego's technology and life science communities.

The 2004 MIP Award winners are:

Tarari, Inc. - Tarari RAX Content Processor (RAX-CP) - the fastest product available for processing XML messages and documents, it implements RAX in hardware to accelerate XPath expressions to query an XML document.

BidShift, Inc. - BidShift v2.1 - Primarily helping to address the current nursing shortage in healthcare, an innovative HCM software tool with an auction-based, shift bidding application to assist hospital administrators to optimize their staffing processes to attract and retain staff and ultimately increase the quality of patient care.

Entropic Communications - c.LINK-270 - a communications semiconductor and software product that enables room-to-room networking at 270Mbps without any changes to existing home wiring.

Life Science:
Ophthonix, Inc. - Z-View Aberrometer & iZon Wavefront-Guided Lenses - a transformational wavefront measurement instrument designed especially for the dispensing eye care practitioner to measure a patient's unique optical fingerprint and achieve a patient's refraction and lead to non-surgical vision optimization.

General Technology:
LIFE-SAFER, INC. -- The Personal Retriever - a patented "Rapid Recovery" system device designed to overcome seven performance deficiencies inherant in traditional drowning rescue tools by raising the effectiveness of the on-scene responder and reducing the level of risk.

Biotechnology R&D:
TargeGen - TG100-115 - a small molecule intravenous drug which reduces tissue damage to the heart following a heart attack by suppressing unwanted biochemical damage.







Toll-Free: (888) 222-0373
Local: (619) 222-3467
Fax: (619) 222-3673

Product Specifications | Customers | Videos | Endorsement Letters
News Articles | Technical Papers | Affiliates | Purchase